Inventor · disambiguated record
Andrew R. Hudson
Also filed as: HUDSON ANDREW · HUDSON ANDREW R · HUDSON ANDREW RICHARD
19 granted patents·12 pending applications·29 citations·filing 2007–2024
91Inventor score
Files withDART NEUROSCIENCE CAYMAN LTD8LIGAND PHARM INC5FL2022 001 INC4DART NEUROSCIENCE LLC3BASF SE2
Top patents by PatentIndex Score
31 records- 0194US9175010B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2013·Granted Nov 3, 2015·12 cites·17 claims
- 0287US9533996B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jan 3, 2017·3 cites·20 claims
- 0386US9499562B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2013·Granted Nov 22, 2016·3 cites·27 claims
- 0484US10092575B2Substituted thiophene- and furan-fused azolopyrimidine-5-(6H)-one compoundsDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 9, 2018·3 cites·10 claims
- 0578US11365191B2Substituted cyclohexyl compounds as NOP inhibiiorsDART NEUROSCIENCE LLC·Filed 2019·Granted Jun 21, 2022·2 cites·25 claims
- 0677US9708334B2Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jul 18, 2017·2 cites·20 claims
- 0777US2025092024A1Substituted cyclohexyl compounds as nop inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0874US11945808B2Substituted cyclohexyl compounds as NOP inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Granted Apr 2, 2024·0 cites·20 claims
- 0973US9144557B2Hematopoietic growth factor mimetic small molecule compounds and their usesZHI LIN·Filed 2010·Granted Sep 29, 2015·3 cites·21 claims
- 1071US10376514B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6H)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Granted Aug 13, 2019·0 cites·20 claims
- 1170US11413274B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2020·Granted Aug 16, 2022·0 cites·8 claims
- 1267US10093907B2Hetero-transglycosylase and uses thereofBAYER CROPSCIENCE NV·Filed 2014·Granted Oct 9, 2018·0 cites·15 claims
- 1367US9622991B2Hematopoietic growth factor mimetic small molecule compounds and their usesLIGAND PHARM INC·Filed 2015·Granted Apr 18, 2017·1 cites·23 claims
- 1466US10736875B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2018·Granted Aug 11, 2020·0 cites·16 claims
- 1565US2025222146A1Radiopharmaceuticals Targeting Somatostatin Receptor 2 and Uses ThereofRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1663US2024252694A1Conjugates comprising covalent binders for targeting intracellular kras g12c proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 1762US10105367B2Therapeutic thiophene-, furan-, and pyridine-fused azolopyrimidin-5-(6h)-onesDART NEUROSCIENCE CAYMAN LTD·Filed 2016·Granted Oct 23, 2018·0 cites·20 claims
- 1861US2022002309A1Ssao inhibitors and uses thereofMETACRINE INC·Filed 2019·Application pending·0 cites
- 1961US2024368127A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2022·Application pending·0 cites
- 2060US10647965B2Hetero-transglycosylase and uses thereofBASF SE·Filed 2018·Granted May 12, 2020·0 cites·4 claims
- 2159US2020181104A1Ssao inhibitors and uses thereofMETACRINE INC·Filed 2020·Application pending·0 cites
- 2258US2020277578A1Hetero-transglycosylase and uses thereofBASF SE·Filed 2020·Application pending·0 cites
- 2357US2024083853A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 2457US2024034736A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 2557US2024083861A1Hsd17b13 inhibitors and uses thereofFL2022 001 INC·Filed 2021·Application pending·0 cites
- 2655US9492430B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2012·Granted Nov 15, 2016·0 cites·12 claims
- 2753US10111859B2Methods and compositions associated with the granulocyte colony-stimulating factor receptorLIGAND PHARM INC·Filed 2016·Granted Oct 30, 2018·0 cites·8 claims
- 2844US2007254917A1Intracellular receptor modulator compounds and methodsHIGUCHI ROBERT I·Filed 2007·Application pending·0 cites
- 2936US10040759B2Substituted azetidinyl compounds as GlyT1 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2015·Granted Aug 7, 2018·0 cites·20 claims
- 3036US2014243324A1Use of hematopoietic growth factor mimeticsBISSONNETTE REID P·Filed 2011·Application pending·0 cites
- 3129US8680150B2Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptorsZHI LIN·Filed 2010·Granted Mar 25, 2014·0 cites·13 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →